reference/28311094

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/28311094

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	45
issn	0140-6736
issueIdentifier	9988
pageRange	31-45
publicationName	Lancet (London, England)
startingPage	31
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e4b7799b7b1f11aa93c9c8c1592f6892 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4aae9edcf98a96e279fa66b5aea8734b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_eee7b3a5510800e72c9ef5d6c9991a09 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_eabd1675394b3812b05c2dd3bca5e590 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b3e030be33391ab082013b7e1906c74a http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_2b0474c946f07c041730926b3f88f9b8 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a647fb40299c3e2342b3b3d0803c8a90 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_77b9befb5f7c1fa9fa46b25378457e72 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_9bba27688d5db96aac8caec0643c0191 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_06aba5a94448c92faf09747c7e7c67bd http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_8075d9d563cbe75004e7b6c2c4360b29 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_6027c801b154b6fc55b8fa23c4f490ce http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d41ed63f3cf7240b8dc535ff384c1e52
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2bbf4be0da0f8ee5c252a03024fe70d5 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e8b35ce7771aea7797be1a2ee68bac2e
bibliographicCitation	RTS,S Clinical Trials Partnership. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet. 2015 Jul 04;386(9988):31–45. PMID: 25913272; PMCID: PMC5626001.
date	2015-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC5626001 https://doi.org/10.1016/s0140-6736%2815%2960721-8 https://pubmed.ncbi.nlm.nih.gov/25913272
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5470 https://portal.issn.org/resource/ISSN/0140-6736
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial
discusses	http://id.nlm.nih.gov/mesh/M0026871
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D016778Q000517 http://id.nlm.nih.gov/mesh/D017780
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D016778Q000453 http://id.nlm.nih.gov/mesh/D007115 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D007117 http://id.nlm.nih.gov/mesh/D015994 http://id.nlm.nih.gov/mesh/D017954Q000453 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D006760Q000706 http://id.nlm.nih.gov/mesh/D007223 http://id.nlm.nih.gov/mesh/D000367 http://id.nlm.nih.gov/mesh/D005500
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8403 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8460 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP02893

Total number of triples: 53.